These results accord with previous reports that RA patients have higher prevalence of sarcopenia than the community-dwelling elderly, and that pro-inflammatory cytokines such as IL-6 and TNF-α participate not only in RA progression but also in frailty development due to catabolic effects on muscles9–11. This evidence concerns the gene IL6 and sarcopenia.